← Browse by Condition
Medical Condition

autoimmune disorders

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT05671757 Phase 1, Phase 2
Recruiting

Daratumumab in Primary Antiphospholipid Syndrome

Enrollment
22 pts
Location
United States
Sponsor
National Institute of Allergy ...
View Trial →